Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
103.60    -1.20 (-1.15%)
Bid:
103.20
Ask:
103.60
Spread: 0.40 (0.388%)
Market Cap: £435.49m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

8 Dec 2011 07:00

RNS Number : 5528T
PZ CUSSONS PLC
08 December 2011
 



8 December 2011

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2011.

 

First half trading

 

The Group's businesses in its core markets of the UK, Indonesia and Nigeria have achieved continued momentum with good revenue growth in the period, however a continued high level of raw material costs and adverse exchange rate movement have impacted margins. In addition, trading conditions in Australia, and in the smaller markets of Greece, Thailand and the Middle East, have been challenging. As a result profit overall for the period has been below expectations.

 

The financial position of the Group is strong with negligible net borrowings at the end of the period.

 

Trading - Update

 

Europe

 

The UK washing and bathing division has experienced good revenue growth despite worsening consumer confidence although continued high levels of promotional activity in the retailers and high raw material prices have put some pressure on margins. New product launches in the period have been well received and include Carex 'Protect Plus' with a new technology that kills bacteria for up to two hours after use.

 

The newly formed beauty division, created following the acquisition of The Sanctuary and more recently St Tropez, has performed well with an increase in revenue and profit despite tougher trading conditions in all UK distribution channels. New product launches have been successful and include the Charles Worthington 'Salon at home' range which has experienced good sales rates since launch in September.

 

Performance in Poland has been robust with revenue and profit ahead of the prior period. Trading conditions in Greece have been difficult as a result of the domestic economic situation.

 

Asia

 

Revenue and profit in Australia are lower than the previous period due to competitive trading conditions in the retailers and high raw material costs.

 

Continued positive momentum in Indonesia has delivered another period of revenue and profit growth largely from the market leading Cussons Baby range.

 

Trading in the Middle East has been affected by social and political unrest in those territories. Supply from Thailand was affected by the recent floods although the situation is now returning to near normal.

 

Africa

 

In Nigeria, revenue growth in all business units has been strong as economic and political stability returns to the country following elections earlier this year. Continued high levels of raw material costs together with a weaker naira have, however, impacted margins in the period. The effect of higher cost of stock together with longer port clearance times have also lead to higher inventory levels as the territory enters peak trading season.

 

Construction of the palm oil refinery with Wilmar in Nigeria is on schedule with completion due by the end of the 2012 calendar year.

 

Performance in Ghana and Kenya has been robust and ahead of the prior period.

 

Directors

 

As announced last month, Helen Owers and Ngozi Edozien will join the board as non-executive directors on 1 January 2012.

 

Full year outlook

 

The trading environment will continue to be difficult given increasing pressures on consumer spending power in all markets, continued high levels of promotional activity in developed markets and the UK in particular, and ongoing high level of input costs.

 

Our focus remains on driving profitable growth for the year through continued brand renovation and margin improvement in all territories.

 

Our strong financial position will enable us to invest in attractive medium term growth opportunities in our core markets in Europe, Asia and Africa.

 

Interim Announcement

 

Interim results for the half year to 30 November 2011 will be announced on Tuesday 24th January 2012.

 

An analysts' presentation will be given at 9:30am on that day at the offices of Panmure Gordon, Moorgate Hall, 155 Moorgate, London EC2M 6XB.

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1016

Brandon Leigh - Finance Director

 

MHP Communications Tel: 020 3128 8100

John Olsen / James White

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGAAPUPGGAM
Date   Source Headline
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale
25th Sep 20193:57 pmRNSResult of AGM
25th Sep 20197:00 amRNSAGM Trading Statement
29th Aug 20197:00 amRNSProposed sale of Minerva and Luksja brand
23rd Aug 201912:15 pmRNSPublication of ARA and Notice of AGM
26th Jul 20198:45 amRNSDirector/PDMR Shareholding
23rd Jul 20197:00 amRNSFinal Results
13th Jun 20197:00 amRNSBoard Change
13th Jun 20197:00 amRNSTrading update
30th Apr 20195:30 pmRNSDirector/PDMR Shareholding
18th Apr 20197:00 amRNSTrading Update
28th Mar 201912:15 pmRNSDirector Declaration
14th Mar 201910:00 amRNSPZ Cussons Plc Director Declaration
30th Jan 201911:10 amRNSInterim Dividend Payment Date
29th Jan 20197:00 amRNSHalf-year Report
23rd Jan 20198:10 amRNSDirector Declaration
13th Dec 20187:00 amRNSTrading Update
13th Nov 201811:09 amRNSHolding(s) in Company
26th Sep 20184:25 pmRNSResult of AGM
26th Sep 20187:00 amRNSAGM Trading Statement
6th Aug 20185:30 pmRNSDirector/PDMR Shareholding
30th Jul 20185:19 pmRNSDirector/PDMR Shareholding
26th Jul 20184:05 pmRNSDirector/PDMR Shareholding
26th Jul 20183:15 pmRNSDirector/PDMR Shareholding
24th Jul 20187:00 amRNSFinal Results
14th Jun 20187:00 amRNSTrading update
2nd May 20187:00 amRNSChange to the Board of Directors
15th Mar 20187:00 amRNSTrading Update
30th Jan 20187:00 amRNSInterim Results
4th Jan 20184:41 pmRNSDirectorate Change
14th Dec 20177:00 amRNSTrading Update
7th Dec 201710:42 amRNSHolding(s) in Company
5th Dec 201710:49 amRNSHolding(s) in Company
27th Sep 20175:30 pmRNSAGM Statement
27th Sep 20177:00 amRNSAGM Trading Statement
30th Aug 20175:30 pmRNSDirector/PDMR Shareholding
28th Jul 20175:30 pmRNSHolding(s) in Company
27th Jul 201711:03 amRNSDirector/PDMR Shareholding
25th Jul 20177:01 amRNSBoard Changes
25th Jul 20177:00 amRNSFinal Results
15th Jun 20177:00 amRNSTrading Update
13th Apr 20177:00 amRNSTrading Update
24th Mar 20177:00 amRNSAppointment of Deloitte LLP as Auditor
13th Mar 201712:24 pmRNSDirector/PDMR Shareholding
1st Feb 20178:45 amRNSDirector/PDMR Shareholding
26th Jan 20175:30 pmRNSDirector/PDMR Shareholding
25th Jan 20175:30 pmRNSDirector/PDMR Shareholding
24th Jan 20177:00 amRNSHalf-year Report
15th Dec 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.